Skip to content

Treatment of plantar fasciitis.

Comparison of dry needling and steroid injection in the treatment of plantar fasciitis: a single-blind randomized clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017082029132N4
Enrollment
70
Registered
2017-08-30
Start date
2013-04-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar fasciitis. Plantar fascial fibromatosis

Interventions

Intervention 1: - Intervention group 1 (steroid group): Following standard sterilization of skin in the plantar region, local needling was performed only on painful point into the plantar fascia. We u
Treatment - Drugs
- Intervention group 1 (steroid group): Following standard sterilization of skin in the plantar region, local needling was performed only on painful point into the plantar fascia. We utilized the 0.3-
- Intervention group 2 (dry-needling group): Following standard sterilization of skin in the plantar region, local needling was performed only on painful point into the plantar fascia. All patients w

Sponsors

Isfahan University of Medical Sciences and Health Services.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: - Inclusion criteria: individuals aged 18 to 70 years old, and a history of plantar heel pain at least for 3 months, who were diagnosed for plantar fasciitis according to the guidelines of Orthopedic Section of the American Physical Therapy Association - exclusion criteria: history of diabetes mellitus, rheumatoid arthritis, flat foot, radiculopathies and foot malignancies, infections, calcaneal spurs and fractures.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The severity of the pain in the plantar fascia. Timepoint: before treatment and at 3 weeks, 6 weeks, 3 months, 6 months and 1 year after the baseline treatment. Method of measurement: Visual Analog Scale (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSajad Badiei

Isfahan University of Medical Sciences and Health Services

s_badiei@edc.mui.ac.ir+98 31 3264 4568

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026